In our view, the DARA story is really starting to come together. We see Soltamox as a $25 million peak opportunity for DARA Bio. Soltamox is a U.S. FDA approved (in 2006) oral liquid formulation of ...
Sabby Management, Dara Biosciences: In a new 13G filing just reported to the SEC, Hal Mintz’s Sabby Management reported an 8.3% stake in DARA Biosciences Inc (NASDAQ:DARA) stock. Due to the nature of ...
Alpha Capital Anstalt: According to a recent SEC filing, Alpha Capital Anstalt now owns around 2.3 million shares of DARA Biosciences Inc (NASDAQ:DARA). Alpha reported a passive stake that amasses ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback